FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic tests
On May 12, 2020, Thermo Fisher Scientific announced the FDA has further expanded emergency use authorization (EUA) for…
Combing through old drugs to find new ones for COVID-19
On May 12, 2020, the Broad Instituteï¾’s Drug Repurposing Hub announced that it had opened its repository of…
LabCorp significantly expanded availability of Its COVID-19 at-home collection test kit
On May 12, 2020, LabCorpï¾® announced that its COVID-19 at-home collection test kit is now being offered to…
Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19
On May 12, 2020, Mylan announced, as part of its ongoing efforts to support patients and public health…
The FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19
On May 11, 2020, the FDA announced actions to accelerate the development of prevention and treatment options for…
NIH report coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key
On May 11, 2020, a harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate…
U of Alberta pharmaceutical institute leads effort to fill looming hospital drug shortage during fight against COVID-19
On May 11, 2020, a University of Alberta-initiated institute leads province wide effort to fill the looming shortage…
SARS-CoV-2 targets many cell types, analysis of single-cell data suggests
On May 11, 2020, HHMI announced that scientists had identified places the new coronavirus, called SARS-CoV-2, may invade…
NanoViricides developed highly effective broad-spectrum drug candidates against Coronaviruses
On May 11, 2020, NanoViricides announced it had developed drug candidates demonstrated very high anti-viral effectiveness in cell…
Thermo Fisher Scientific to double its capacity of viral vector manufacturing
On May 11, 2020, Thermo Fisher Scientific announced it is expanding capacity for viral vector development and manufacturing…
NIH clinical trial testing antiviral remdesivir plus antiiInflammatory drug baricitinib for COVID-19 began
On May 8, 2020, the NIH announced that a randomized, controlled clinical trial evaluating the safety and efficacy…
The FDA issued EUA for first diagnostic test using at-home collection of saliva specimens
On May 8, 2020, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for…
Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies or COVID-19 therapy
On May 8, 2020, the Council of Scientific and Industrial Research (CSIR) under its flagship programme NMITLI announced…
OPKO Health’s BioReference Laboratories launched COVID-19 antibody screening for New York City residents
On May 8, 2020, BioReference Laboratories, an OPKO Health company, announced the launch of COVID-19 antibody screening available…
The Defense Health Agency collaborated to further sequence the SARS-CoV-2 code
On May 7, 2020, the Defense Health Agency announced that the Air Force Genetics Center of Excellence at…
NIH-supported research examines impact of COVID-19 on rare diseases community
On May 7, 2020, the NIH announced a new online survey launched by the NIH-supported Rare Diseases Clinical…
Risk factors for COVID-19 death revealed in worldï¾’s largest analysis of patient records to date
On May 7, 2020, academics at the University of Oxford and the London School of Hygiene & Tropical…
Sanger scientist received Chan Zuckerberg Initiative support for COVID-19 study
On May 7, 2020, the Wellcome Sanger Institute announced that Roser Vento-Tormo, a Group Leader was one of…
UNMC researcher one of 12 in US to receive grant to study heart health related to COVID-19
On May 7, 2020, Rebekah Gundry, Ph.D., was one of only 12 investigators nationwide to receive a “COVID-19…
Catalent partnered with Humanigen to support FDA approved phase 3 lenzilumab study for COVID-19
On May 7, 2020, Catalent announced Phase 3 study for lenzilumab, the companyï¾’s proprietary Humaneeredï¾® anti-human granulocyte macrophage-colony…
Tonix Pharma announced a research collaboration and exclusive agreement with the University of Alberta to develop novel c-based vaccines for prevention of COVID-19
On May 7, 2020, Tonix Pharmaceuticals and the University of Alberta announced a research collaboration and exclusive licensing…
CoVIg-19 Plasma Alliance builds strong momentum through expanded membership and clinical trial collaboration
On May 7, 2020, the CoVId-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the…
Sinovac announced first animal study results of vaccine against COVID-19 published in SCIENCE
On May 6, 2020, Sinovac Biotech announced publication of the preclinical study on animals for its vaccine candidate…
Miami University confirmed high quality of IGEA’s COVID-19 rapid test
On May 6, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…
PharmaCyte Biotech received medical devices registration and submited pre-EUA application to the FDA for COVID-19 diagnostic kit
On May 6, 2020, PharmaCyte Biotech announced it had received Medical Devices Establishment Registration with the FDAï¾’s Center…
First patient dosed in FDA-approved phase III lenzilumab study for COVID-19
On May 6, 2020, Humanigen announced that the first COVID-19 patient had been dosed in its previously announced…
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
Predictive Oncology launched new AI platform for vaccine and drug development targeting coronaviruses and Acute Respiratory Syndromes
On May 6, 2020, Predictive Oncology announced the acquisition of Soluble Therapeutics and partnership and licensing of a…
Meridian Bioscience partnered with QuantuMDx on COVID-19 assay
On May 6, 2020, Meridian Bioscience announced a collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for…
Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccine
On May 5, 2020, Medigen Vaccine Biologics (MVB) announced a global commercial license agreement with National Institutes of…